By Sheri Kasprzak
New York, Dec. 5 - Antisoma plc said it has completed a private placement for £6,552,000.
The company issued 33.6 million shares at 19.5p each to new and existing institutional investors in the United Kingdom and continental Europe.
The price per share was a 4.88% discount to the closing middle market price of the company's stock on Dec. 2.
ING was the placement agent for the offering.
Based in London, Antisoma is a biopharmaceutical company focused on developing novel treatments for cancer.
| Issuer: | Antisoma plc
|
| Issue: | Stock
|
| Amount: | £6,552,000
|
| Shares: | 33.6 million
|
| Price: | 19.5p
|
| Warrants: | No
|
| Placement agent: | ING
|
| Settlement date: | Dec. 5
|
| Stock price: | 20.35p at close Dec. 2
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
